Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published September 15, 1984 | Published
Journal Article Open

Cloning of terminal transferase cDNA by antibody screening

Abstract

A cDNA library was prepared from a terminal deoxynucleotidyltransferase-containing thymoma in the phage vector λgt11. By screening plaques with anti-terminal transferase antibody, positive clones were identified of which some had β-galactosidase-cDNA fusion proteins identifiable after electrophoretic fractionation by immunoblotting with anti-terminal transferase antibody. The predominant class of cross-hybridizing clones was determined to represent cDNA for terminal transferase by showing that one representative clone hybridized to a 2200-nucleotide mRNA in close-matched enzyme-positive but not to enzyme-negative cells and that the cDNA selected a mRNA that translated to give a protein of the size and antigenic characteristics of terminal transferase. Only a small amount of genomic DNA hybridized to the longest available clone, indicating that the sequence is virtually unique in the mouse genome.

Additional Information

© 1984 by the National Academy of Sciences. Contributed by David Baltimore, May 23, 1984. This work was supported by American Cancer Society Grant IM-355 to D.B., National Cancer Institute Grant CA14051 (core grant to S.E. Luria), National Cancer Institute Grant CA22599 and American Cancer Society Grant CH256 to A.E.S., and National Institutes of Health Grant AI18162 to I.L.W. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Attached Files

Published - LANpnas84.pdf

Files

LANpnas84.pdf
Files (1.8 MB)
Name Size Download all
md5:6659c5d6434cd0528ac6db6917465577
1.8 MB Preview Download

Additional details

Created:
August 22, 2023
Modified:
October 16, 2023